Estimation of average treatment effects among multiple treatment groups by using an ensemble approach.

average treatment effect ensemble doubly robust method generalized propensity score multiple treatment groups

Journal

Statistics in medicine
ISSN: 1097-0258
Titre abrégé: Stat Med
Pays: England
ID NLM: 8215016

Informations de publication

Date de publication:
10 07 2019
Historique:
received: 13 03 2018
revised: 10 12 2018
accepted: 23 02 2019
pubmed: 4 4 2019
medline: 6 11 2020
entrez: 4 4 2019
Statut: ppublish

Résumé

In observational studies, generalized propensity score (GPS)-based statistical methods, such as inverse probability weighting (IPW) and doubly robust (DR) method, have been proposed to estimate the average treatment effect (ATE) among multiple treatment groups. In this article, we investigate the GPS-based statistical methods to estimate treatment effects from two aspects. The first aspect of our investigation is to obtain an optimal GPS estimation method among four competing GPS estimation methods by using a rank aggregation approach. We further examine whether the optimal GPS-based IPW and DR methods would improve the performance for estimating ATE. It is well known that the DR method is consistent if either the GPS or the outcome models are correctly specified. The second aspect of our investigation is to examine whether the DR method could be improved if we ensemble outcome models. To that end, bootstrap method and rank aggregation method are used to obtain the ensemble optimal outcome model from several competing outcome models, and the resulting outcome model is incorporated into the DR method, resulting in an ensemble DR (enDR) method. Extensive simulation results indicate that the enDR method provides the best performance in estimating the ATE regardless of the method used for estimating GPS. We illustrate our methods using the MarketScan healthcare insurance claims database to examine the treatment effects among three different bones and substitutes used for spinal fusion surgeries. We draw conclusions based on the estimates from the enDR method coupled with the optimal GPS estimation method.

Identifiants

pubmed: 30941812
doi: 10.1002/sim.8146
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

2828-2846

Subventions

Organisme : NIH HHS
ID : 1R03DE026757-01A1
Pays : United States

Informations de copyright

© 2019 John Wiley & Sons, Ltd.

Auteurs

Xiaofang Yan (X)

Department of Bioinformatics and Biostatistics, University of Louisville, Louisville, Kentucky.

Younathan Abdia (Y)

Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

Somnath Datta (S)

Department of Bioinformatics and Biostatistics, University of Louisville, Louisville, Kentucky.
Department of Biostatistics, University of Florida, Gainesville, Florida.

K B Kulasekera (KB)

Department of Bioinformatics and Biostatistics, University of Louisville, Louisville, Kentucky.

Beatrice Ugiliweneza (B)

Department of Neurosurgery, University of Louisville, Louisville, Kentucky.

Maxwell Boakye (M)

Department of Neurosurgery, University of Louisville, Louisville, Kentucky.

Maiying Kong (M)

Department of Bioinformatics and Biostatistics, University of Louisville, Louisville, Kentucky.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH